Biogen (BIIB) - Hot M&A

Biogen (BIIB) – Hot M&A

Jul 28, 2023 07:41 AM Biogen agrees to acquire neurological disease specialist Reata Pharmaceuticals at 60% premium
Jul 28, 2023 07:07 AM Biogen (BIIB) to Acquire Reata Pharmaceuticals (RETA) for $172.50/Share, Approximately $7.3 Billion
Jul 28, 2023 06:49 AM
Jan 13, 2022 02:22 PM
Dec 29, 2021 11:59 PM
Dec 29, 2021 02:10 PM
Mar 4, 2019 05:53 AM
Jan 19, 2018 06:16 AM
Aug 3, 2016 02:23 PM
Aug 3, 2016 05:16 AM
Aug 2, 2016 05:26 PM
Aug 2, 2016 02:49 PM
Aug 2, 2016 02:46 PM
Apr 8, 2016 02:45 PM